SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-002971
Filing Date
2024-02-02
Accepted
2024-02-02 16:49:10
Documents
16
Period of Report
2024-01-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A vxrt20240202_8ka.htm   iXBRL 8-K/A 29712
2 EXHIBIT 10.1 ex_622122.htm EX-10.1 103718
  Complete submission text file 0001437749-24-002971.txt   294408

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240115.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240115_def.xml EX-101.DEF 11791
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240115_lab.xml EX-101.LAB 15820
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240115_pre.xml EX-101.PRE 12006
17 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240202_8ka_htm.xml XML 3003
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35285 | Film No.: 24592325
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)